Anton Shakhmin

Anton Shakhmin has extensive work experience in the field of scientific research and chemistry. Anton began their career in 2001 as an Undergraduate Research Associate at Saint-Petersburg State University, where they worked until 2006. In 2005, they also worked as an Intern in Superacid Catalysis at the University of Southern California. Anton then joined the University of Leipzig as an Intern in Rh (II) Catalysis from January to June 2007.

From 2007 to 2013, Anton worked as a Graduate Research Associate at the University of Southern California. Following that, they served as a Medicinal Chemist at Agensys, Inc. for three months in 2014. Anton also worked as a Postdoctoral Research Fellow at Promega Biosciences from June 2014 to May 2016.

In 2016, Anton joined Nanosyn as a Research Scientist, where they worked until June 2018. Anton then became a Scientist I at Achaogen from June to December 2018. In 2019, they worked as a Scientist I at FLX Bio, Inc. from January to May, and then shifted to RAPT Therapeutics as a Scientist I from May 2019 to July 2021. Anton was later promoted to Scientist II at RAPT Therapeutics in July 2021, and they continue to work in this position.

Overall, Anton Shakhmin's work experience demonstrates their expertise in scientific research and their progression in various roles within the field.

Anton Shakhmin completed their education in organic chemistry with a Master of Science (M.Sc.) degree from Saint-Petersburg State University in the years 2001 to 2006. Anton continued their educational journey at the University of Southern California, where they pursued a Doctor of Philosophy (Ph.D.) degree in Organic/Medicinal Chemistry from 2007 to 2013.